Streetbeat News

Products Services

TSLA

Tesla, Inc. is set to offer a one-month free trial of its Full-Self Driving (FSD) software in Canada, matching the US offer, once regulatory and technical issues are resolved. This move is part of Tesla's strategy to explore high-margin recurring revenue streams amid challenges in the core auto business. The announcement was made by a senior Tesla executive in response to a user's query on social media, highlighting Tesla's increased engagement on such platforms to improve communication and transparency.

Portfolio Pulse from Shanthi Rexaline

March 26, 2024 | 8:32 am

GS

Goldman Sachs forecasts a 15% increase in the S&P 500 by the end of 2024, driven by the performance of mega-cap tech stocks and the AI boom. The bank's chief equity strategist, David Kostin, predicts the index could reach 6,000, citing that tech stocks are not in a bubble and have profitable growth. The top seven tech stocks are expected to see a 12% annualized sales growth from 2023 to 2025, significantly outpacing the rest of the market. The AI boom, highlighted by Nvidia's GPU Tech Conference, is expected to continue fueling growth.

Portfolio Pulse from Benzinga Neuro

March 26, 2024 | 7:51 am

TM

TSLA

Ross Gerber, CEO of Gerber Kawasaki, stated on CNBC that consumers prefer electric vehicles (EVs) over hybrids, highlighting Tesla Inc.'s (NASDAQ:TSLA) superior battery performance. This shift aligns with Elon Musk's vision for Tesla to become the top automaker by 2030, potentially impacting the automotive industry and Japanese equities, including Toyota Motor Corporation (NYSE:TM), which recently refocused on hybrids.

Portfolio Pulse from Benzinga Neuro

March 26, 2024 | 7:21 am

ARGX

argenx has received approval for VYVGART in Japan for treating adults with primary immune thrombocytopenia (ITP), marking its first global approval for this indication. VYVGART is now approved in Japan for both generalized myasthenia gravis and ITP.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 7:15 am

SOLUSD

TSLA

Richard Dawkins, known for coining the term 'meme', received a cryptocurrency named after him, Dawkoin, as a birthday present. Elon Musk, CEO of Tesla and a cryptocurrency enthusiast, acknowledged this with a laugh. Dawkoin, which credits Dawkins as the 'father of MEMEs', has a total supply of 1 billion and can be bought by converting Solana (SOL) on the Raydium platform. Investors are advised to be cautious with meme coins like Dawkoin due to their speculative nature.

Portfolio Pulse from Ramakrishnan M

March 26, 2024 | 7:12 am

NXU

Nxu has launched the NxuOne™ mobile app, designed to enhance the electric vehicle (EV) charging experience by integrating with the NxuOne™ EV Charging Systems. This app provides users with a streamlined view of their charging sessions, offering more efficiency and convenience.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 7:04 am

ZS

Zscaler, Inc. and BT have expanded their partnership, making BT the first global service provider to offer a full suite of managed security services using Zscaler's AI-driven Zero Trust Exchange cloud security platform. This collaboration aims to simplify IT infrastructures, reduce cyber-attack surfaces, and enhance business agility, efficiency, resilience, and security.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 7:03 am

IFF

IFF is set to present its science-driven excipient solutions at CPhI Japan 2024, showcasing its commitment to innovation in the pharmaceutical industry.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 6:52 am

ICE

Kasikorn Securities has chosen Intercontinental Exchange (ICE) for improved portfolio analytics and risk management concerning derivatives. This partnership aims to leverage ICE's advanced technology and extensive experience in the financial markets to enhance Kasikorn Securities' derivatives analytics and risk management capabilities.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 6:49 am

BSX

Scivita Medical has expanded its collaboration with Boston Scientific for strategic co-development and global distribution activities. This partnership aims to leverage both companies' strengths in medical technology and distribution networks to enhance their global market presence.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 5:51 am